Clinical Trials Browser

Phase 1 × Glioblastoma × rocakinogene sifuplasmid × Clear all

NCT04015700 2026-02-09

Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Phase 1 Active not recruiting

Glioblastoma